Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRY | TBPH | BVS | ||
| Company | Ars Pharmaceuticals Inc | Theravance Bio Ord | Bioventus Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.09 | 17.40 | 9.64 | ||
| High | 8.97 | 17.74 | 9.88 | ||
| Low | 7.97 | 17.29 | 9.42 | ||
| Latest | 8.54 | 17.63 | 9.78 | ||
| Change | +0.52 | +0.24 | +0.05 | ||
| % Change | +6.48% | +1.38% | +0.51% | ||
| Volume | 5,015,400 | 1,311,400 | 1,435,000 | ||
| 20-Day Average Volume | 2,002,425 | 518,220 | 707,950 | ||
| Previous Close | 8.02 | 17.39 | 9.73 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.36 | 16.53 | 8.84 | ||
| 20-Day Raw Stochastic | 30.86% | 95.05% | 95.17% | ||
| 20-Day Relative Strength | 46.88 | 64.27 | 56.24 | ||
| Weighted Alpha | -49.15 | +58.58 | +46.42 | ||
| Today's Opinion | 56% Sell | 8% Sell | 64% Buy | ||
| Previous Opinion | 48% Sell | 24% Sell | 64% Buy | ||
| Last Month's Opinion | 56% Sell | 32% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.50% since 06/18/26 | +6.33% since 06/18/26 | +12.28% since 06/18/26 | ||
| Low | 7.50 on 06/25/26 | 16.41 on 06/22/26 | 8.63 on 06/22/26 | ||
| High | 10.87 on 06/24/26 | 17.74 on 06/26/26 | 9.88 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +4.53% since 05/26/26 | +7.43% since 05/26/26 | +8.43% since 05/26/26 | ||
| Low | 7.50 on 06/25/26 | 15.52 on 06/02/26 | 7.81 on 06/02/26 | ||
| High | 10.87 on 06/24/26 | 17.74 on 06/26/26 | 9.88 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | -0.23% since 03/26/26 | +16.06% since 03/26/26 | +5.62% since 03/26/26 | ||
| Low | 7.03 on 05/15/26 | 14.70 on 03/30/26 | 7.81 on 06/02/26 | ||
| High | 10.87 on 06/24/26 | 17.74 on 06/26/26 | 11.25 on 05/07/26 | ||
| 6-Month | |||||
| %Chg | -24.96% since 12/26/25 | -6.42% since 12/26/25 | +31.10% since 12/26/25 | ||
| Low | 7.03 on 05/15/26 | 13.08 on 03/03/26 | 7.14 on 01/02/26 | ||
| High | 13.15 on 01/12/26 | 21.03 on 01/22/26 | 11.25 on 05/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 848,048 | 908,879 | 816,972 | ||
| Shares Outstanding, K | 99,303 | 51,553 | 83,535 | ||
| Annual Sales | 84,280,000 | 107,460,000 | 568,090,000 | ||
| Annual Net Income | -171,300,000 | 105,900,000 | 22,730,000 | ||
| Last Quarter Sales | 22,680,000 | 17,700,000 | 132,090,000 | ||
| Last Quarter Net Income | -60,620,000 | -4,930,000 | 3,110,000 | ||
| 60-Month Beta | 0.94 | 0.17 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.61 on 05/15/26 | 0.01 on 05/07/26 | 0.15 on 05/06/26 | ||
| Earnings Date | 08/12/26 | 08/11/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.11 | 12.97 | ||